Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
Leqembi® Iqlik™ PDUFA date updated to August 24 in the U.S.
08 May 2026
PR Newswire Association LLC.
Oblique Therapeutics today announced that Dr. Jan Lundberg has joined the company as Scientific Advisor
08 May 2026
PR Newswire Association LLC.
Bioretec Ltd's resolutions of the constitutive meeting of the Board of Directors
08 May 2026
GlobeNewswire
Evaxion announces business update and first quarter 2026 financial results
07 May 2026
GlobeNewswire
Zealand Pharma initiates USD 200 million / DKK 1.3 billion share buy-back program
07 May 2026
GlobeNewswire
Zealand Pharma Announces Financial Results for the First Three Months of 2026
07 May 2026
GlobeNewswire
Annexon Reports First Quarter 2026 Financial Results, Portfolio Progress and Key Anticipated Milestones
07 May 2026
GlobeNewswire
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
07 May 2026
PR Newswire Association LLC.
For the Reasons that Matter: A Multi-Spotlight Campaign Puts Adult Respiratory Health in Focus
07 May 2026
GlobeNewswire
Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities
07 May 2026
GlobeNewswire
Omada Health Joins Lilly Employer Connect, Expanding Its Access Pathways for GLP-1 Care as Patients Seek More Lifestyle Support
07 May 2026
GlobeNewswire
CJ Biomaterials and Yuhan-Kimberly Launch World’s First Reusable Nonwoven Paper Towel Made with Amorphous PHA
07 May 2026
GlobeNewswire
New 2-Year Data from Pivotal ApproaCH Trial of TransCon® CNP (Navepegritide) Show Pronounced Gains in Growth Outcomes in Children with Achondroplasia Aged ≥5 Years
06 May 2026
PR Newswire Association LLC.
The Foundation Assar Gabrielsson Prize recipients 2026 awarded
06 May 2026
PR Newswire Association LLC.
Debut and Oterra partner to develop and scale biotech alternative to Red 40 for food and beverage
06 May 2026
PR Newswire Association LLC.
Ribo and Boehringer Ingelheim further progress their siRNA program for metabolic dysfunction-associated steatohepatitis (MASH)
06 May 2026
GlobeNewswire
CRYSVITA® Now Publicly Reimbursed for the Treatment of Adults with XLH in Four Provinces and Federal Non-Insured Health Benefits Program
06 May 2026
PR Newswire Association LLC.
Jazz Pharmaceuticals Announces First Quarter 2026 Financial Results
05 May 2026
Latest News All News
Upcoming Events All Events
- May 2026
- Copenhagen: LSX Nordic Congress
- Basel: Pharma Partnering EU Summit 2026
- London: UK Biotech Day